HCV ERADICATION RESULTS IN REDUCTION OF HEPATIC VENOUS PRESSURE GRADIENT 48 WEEKS AFTER END OF TREATMENT; FINAL RESULTS OF THE STUDY OF SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION

被引：6

作者：

Afdhal, N. ^{[1
]}

Asselah, T. ^{[2
,3
]}

Everson, G. T. ^{[4
]}

Bosch, J. ^{[5
]}

De-Oertel, S. ^{[6
]}

Brainard, D. M. ^{[6
]}

McHutchison, J. G. ^{[6
]}

Yang, Y. ^{[6
]}

Watt, K. D. ^{[7
]}

Curry, M.

Gane, E. ^{[1
,8
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[2] Hop Beaujon, INSERM, UMR 1149, Clichy, France

[3] Univ Paris Diderot, Clichy, France

[4] Univ Colorado, Aurora, CO USA

[5] CIBEREHD, Liver Unit, IDIBAPS, Barcelona, Spain

[6] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[7] Mayo Clin, Rochester, MN USA

[8] Univ Auckland, Auckland, New Zealand

来源：

关键词：

D O I：

10.1016/S0168-8278(16)00195-1

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LBP518

引用

页码：S221 / S222

页数：2